Earlier in September WebMD conducted a tender offer in which it repurchased 5.0 million shares of its common stock, offering a price of $34 apiece, with the value of the deal amounting to $170 million. In the second quarter, WebMD posted EPS of $0.27, beating the average estimates by nearly 70%. Another recent highlight in the company's life is the appointment of the interim CEO David J. Schlanger as the full CEO, and the appointment of Steven L. Zatz, M.D. as its President.
Below you can find the stock purchase agreement signed between Icahn and WebMD:Coghill Capital Unloads Some Autobytel Shares Activist Joseph Stillwell Gets a Board Nominee at Malvern Bancorp ClickSoftware Technologies: Discovery Group Now Holds 5.6%